Overview

Gender

male

Jeff has spent his career in the discovery and development of new chemical entities for the treatment of unmet medical needs. His Discovery experience spans target ID to candidate selection, and his Development Chemistry expertise spans IND-enabling studies to pivotal clinical trials.

Jeff has held positions of increasing responsibility at Affymax, Vicuron and Sunesis, where he was most recently Senior Director of Development Chemistry.

Jeff graduated Magna cum Laude with a B.S. in Chemistry, Honors, from Gonzaga University. He received his Ph.D. in Bioorganic Chemistry at U.C. Berkeley where he started the catalytic antibody program in the laboratory of Professor Peter Schultz.

He is a Damon-Runyon Fellow and an author and inventor on over 50 scientific papers and patents.